Simcere Pharmaceutical Files HKEX Return Disclosing Share Buyback for Cancellation

• Simcere Pharmaceutical repurchased 528,000 shares for HKD 5.36 million on November 3, 2026.
• The average repurchase price was HKD 10.1579 per share; all 528,000 shares are awaiting cancellation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Simcere Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261103-12397962), on November 03, 2026, and is solely responsible for the information contained therein.